Invention Grant
- Patent Title: Highly pure neurotoxic component of a botulinum toxin and uses thereof
-
Application No.: US15881135Application Date: 2018-01-26
-
Publication No.: US10653754B2Publication Date: 2020-05-19
- Inventor: Michael Pfeil , Andreas Wiesenburg
- Applicant: MERZ PHARMA GMBH & CO. KGAA
- Applicant Address: DE Frankfurt am Mein
- Assignee: Merz Pharmaceuticals GmbH
- Current Assignee: Merz Pharmaceuticals GmbH
- Current Assignee Address: DE Frankfurt am Mein
- Agency: McBee Moore & Vanik IP, LLC
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@94b21dd
- Main IPC: A61K39/08
- IPC: A61K39/08 ; A61K38/48 ; C07K14/33 ; C12M1/12 ; C12M1/34 ; C12N1/20 ; C12N9/52
Abstract:
The present invention relates to a process for preparing a highly pure neurotoxic component of a botulinum toxin by cultivating Clostridium botulinum under conditions that allow production of a botulinum toxin, and isolating the neurotoxic component from the botulinum toxin. In addition, the present invention relates to a highly pure neurotoxic component of a botulinum toxin obtainable by the process of the present invention and uses thereof.
Public/Granted literature
- US20180147266A1 HIGHLY PURE NEUROTOXIC COMPONENT OF A BOTULINUM TOXIN, PROCESS FOR PREPARING SAME, AND USES THEREOF Public/Granted day:2018-05-31
Information query
